Evommune, Inc. · NYSE:EVMN

Cohen David E sold 6,056 Evommune, Inc. shares (Form 4)

Traded Jun 2, 2026 · Filed Jun 3, 2026

On Jun 2, 2026, Cohen David E (Director) sold 6,056 Evommune, Inc. shares at an average US$20.33 for US$123K under a trading plan, leaving 17,609 shares. Filed Jun 3, 2026 (Form 4).

Sold
6,056 shares
Price
US$20.33 average (US$20.21 to US$21.38)
Value
US$123K
Holding after
17,609 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 2, 2026Common StockSale5,456US$20.2118,209Direct
Jun 2, 2026Common StockSale600US$21.3817,609Direct

Source

View original at SEC

Related